Case study: persistent keratitis OS presents in 68-year-old woman

Publication
Article
Optometry Times JournalDigital edition: January 2022
Volume 14
Issue 01

A 68-year-old White woman was referred for persistent keratitis OS and failure on multiple medications. Find out her official diagnosis and treatment plan.

Figure 1. Infectious keratitis before application of Prokera Slim.

Figure 1. Infectious keratitis before application of Prokera Slim.



Presentation

A 68-year-old White woman was referred for persistent keratitis OS and failure on multiple medications: Restasis, Xiidra, prednisolone 1%, Lotemax 0.5%, and Cequa. She was using Systane preservative-free drops, 4 to 6 times daily. Sodium fluorescein staining revealed marked keratitis OS (Figure 1).

Greg Caldwell

Caldwell

Treatment

I educated the patient about her condition, and after lengthy discussion it was decided that a Prokera Slim amniotic membrane would be used to treat the OS.

Follow-up

I instructed my patient to make an appointment to have the Prokera ring removed when her vision cleared (due to membrane dissolving). Her vision cleared 6 days after Prokera Slim insertion. At this point, she was only using Systane preservative-free artificial tears. The ring was removed, and the patient was placed on autologous serum eye drops 20%, 1 drop 6 times per day.

Figure 2. The eye 6 days after application of Prokera Slim. (All figures courtesy of Greg Caldwell, OD, FAAO)

Figure 2. The eye 6 days after application of Prokera Slim. (All figures courtesy of Greg Caldwell, OD, FAAO)


Outcome and observations

The patient presented with a chronic and persistent keratitis OS. The cause was multifactorial with 1 component being toxic keratitis from the various pharmaceuticals used. This patient needed a therapy that supported wound healing and not wound covering. A Prokera Slim was used to provide wound healing. The patient reported no problems or discomfort with Prokera Slim during the 6-day treatment (Figure 2).

The patient responded wonderfully to the therapy and reported increased comfort and improved vision.

READ Dr.Caldwell's full article: Cryopreserved amniotic membrane excels at healing ocular surface wounds

Recent Videos
EyeCon 2024: Insights on transforming ocular surface disease management
EyeCon 2024: Kelly Nichols, OD, and A. Paul Chous, OD, discuss multidisciplinary care and AI in diabetes management
Laura Periman, MD, discusses a case study in Demodez blepharitis
Jessilin Quint, OD, MBA, FAAO, overviews her presentations at Vision Expo West.
Jeffry Gerson, OD, FAAO, chats with Optometry Times about his talks about retina conditions at Vision Expo West
Marc Bloomenstein, OD, FAAO, gives overview of education available at Vision Expo West
Mile Brujic, OD, FAAO, gives overview of how to start a speciality contact lens practice
Danica Marrelli, OD, FAAO, AAO Dip, talks OCT and glaucoma
Jeffry Gerson, OD, FAAO, overviews a presentation he gave at VEW 2024 on AMD
Mark Dunbar, OD, FAAO, gives overview of advancements in GA treatment
© 2024 MJH Life Sciences

All rights reserved.